Increased Productivity through Dynamic Process Optimization in Sterile Facility 303 at Novartis Pharma Stein AG

Pharmaceutical production processes are subject to a multiplicity of regulatory requirements regarding the product quality. Since economic aspects (e.g. productivity) also have to be considered, process optimizations have to be carried out. In Building 303 at Novartis Pharma Stein AG new technologie...

Full description

Saved in:
Bibliographic Details
Published inChimia Vol. 58; no. 9
Main Authors Peter Nyfeler, Antonio Zeoli, Cédric Bokalota, Roland Chatelain
Format Journal Article
LanguageEnglish
German
Japanese
Published Swiss Chemical Society 01.09.2004
Subjects
Maximization of production output
Pharmaceutical production
Regulatory requirements
Online AccessGet full text

Cover

More Information
Summary:Pharmaceutical production processes are subject to a multiplicity of regulatory requirements regarding the product quality. Since economic aspects (e.g. productivity) also have to be considered, process optimizations have to be carried out. In Building 303 at Novartis Pharma Stein AG new technologies have been implemented, which are constantly reviewed and optimized to increase the productivity and to keep up with the state of the art and the requirements.
ISSN:0009-4293
2673-2424
DOI:10.2533/000942904777677551